WASHINGTON, Feb 4 (Reuters) – The U.S. Senate Finance Committee on Monday invited seven pharmaceutical companies to testify on Feb. 26 about drug pricing, the panel said in a statement.
AbbVie Inc, AstraZeneca PLC, Bristol-Myers Squibb Co, Johnson & Johnson, Merck & Co Inc , Pfizer Inc and Sanofi SA have been invited to testify, the statement said.
Reporting by Eric Beech; Editing by David Alexander
Our Standards:The Thomson Reuters Trust Principles.